You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

NULYTELY-FLAVORED Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

When do Nulytely-flavored patents expire, and what generic alternatives are available?

Nulytely-flavored is a drug marketed by Braintree and is included in one NDA.

The generic ingredient in NULYTELY-FLAVORED is polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride. There are four hundred and twenty-one drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for NULYTELY-FLAVORED?
What are the global sales for NULYTELY-FLAVORED?
What is Average Wholesale Price for NULYTELY-FLAVORED?

Summary for NULYTELY-FLAVORED

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Clinical Trials:	9
DailyMed Link:	NULYTELY-FLAVORED at DailyMed

Drug patent expirations by year for NULYTELY-FLAVORED

Recent Clinical Trials for NULYTELY-FLAVORED

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Gastroenterology Services, Ltd.
ColonaryConcepts LLC	Phase 2
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran	Phase 3

See all NULYTELY-FLAVORED clinical trials

US Patents and Regulatory Information for NULYTELY-FLAVORED

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Braintree	NULYTELY-FLAVORED	polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride	FOR SOLUTION;ORAL	019797-002	Nov 18, 1994	AA	RX	Yes	Yes	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.